Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

First Annual Rheumatoid Awareness Day to Be Held February 2

Michael O’Neal  |  February 2, 2013

Besides Groundhog Day, this February 2 will stand for something that many believe is long overdue for its own day of recognition. The Rheumatoid Patient Foundation (RPF), a nonprofit dedicated to helping patients with rheumatoid arthritis, has announced the first annual Rheumatoid Awareness Day, which will be held on February 2, 2013, and every year thereafter.

Kelly Young, the RPF’s founder, says that since rheumatoid disease is not just a type of arthritis, the general public awareness of the disease needs some enhancement. “We like to say that arthritis is a symptom of rheumatoid disease; it’s not what it is. It’s not exactly accurate to name the disease by one symptom,” Young said in an interview.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Young believes that getting the word out about how rheumatoid arthritis is often misunderstood will go beyond benefitting patients. “I think increased awareness of the disease will benefit rheumatologists as it benefits patients, because most people are not diagnosed early,” she said. “So increased awareness will lead to earlier referrals, and it will probably lead to eventually increased research dollars and much better responses within the government.”

Young cites several factors for choosing February 2 for the new annual awareness day. “We had decided to focus on February because of it being heart disease month and our desire to change the perception of the disease from being a hand disease with only joint symptoms to being a chronic, systemic disease that affects mortality, and often because of heart disease that’s actually related to [rheumatoid] disease itself,” Young said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The RPF will be hosting a series of online discussions on Friday, February 1, and Saturday, February 2, featuring rheumatologists John Davis, III, MD, research chair of the division of rheumatology at the Mayo Clinic in Rochester, Minn., and Jeffrey Curtis, MD, MPH, assistant professor of medicine and director of the arthritis clinical intervention program at the University of Alabama, Birmingham. Through the use of social media and grassroots outreach efforts online and in local communities and government, rheumatologists, patients, and their families are working to spread the word about the prevalence of rheumatoid arthritis in society.

“This is long overdue,” Young said. “It’s an obvious need because this is something that’s been done and has been useful for many other conditions that are similar or as serious as this one. With this disease being kind of a common disease, it’s long overdue that we have acknowledgement and awareness and patients bring voice to their experience and to what their needs are.”

Page: 1 2 | Single Page
Share: 

Filed under:Patient PerspectiveRheumatoid Arthritis Tagged with:AdvocacyPatientsRheumatoid arthritis

Related Articles

    Case Report: Atypical Presentation of Idiopathic Retroperitoneal Fibrosis

    March 14, 2022

    Retroperitoneal fibrosis (RPF) is a rare condition characterized by aberrant fibroinflammatory tissue developing in the retroperitoneum. This disorder was initially called Ormond’s disease. RPF may be idiopathic or secondary to other conditions. Idiopathic RPF is a part of the disease spectrum of chronic periaortitis due to its typical periaortoiliac localization. Idiopathic retroperitoneal fibrosis is a…

    Cutaneous Lupus Tied to Risk for Coexisting Autoimmune Conditions

    May 10, 2018

    NEW YORK (Reuters Health)—Patients with cutaneous lupus erythematosus (CLE) should be monitored closely for other autoimmune conditions, researchers suggest. Dr. Benjamin Chong, Dr. Linda Hynan and Elaine Kunzler of the University of Texas Southwestern Medical Center in Dallas analyzed data from 129 adults in the UTSW Cutaneous Lupus Registry (mean age, 49; 79% women). Individuals…

    Fibrotic Diseases of the Retroperitoneum & Skin, & Rare Scleroderma Mimics

    January 19, 2018

    SAN DIEGO—Fibrosis affects all organ systems, but isn’t always systemic sclerosis. Experts on less common forms discussed patient presentations, diagnosis and treatment at the 2017 ACR/ARHP Annual Meeting in San Diego on Nov. 6. Retroperitoneal Fibrosis Formerly called Ormond’s disease, retroperitoneal fibrosis (RPF) is usually an IgG4-related disease, but has some unique characteristics, said John…

    Rheumatoid Arthritis Practice Performance Project Spots Problems in RA Management

    June 15, 2015

    Rheumatologists have growing concerns about how we manage rheumatoid arthritis (RA) and the disease outcomes we are achieving.1 Over the past two years, clinician rheumatologists have begun working together to address these problems through the Rheumatoid Arthritis Practice Performance (RAPP) Project, a nationwide clinical quality-improvement initiative. The RAPP Project has now grown to 168 participants…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences